The link between aberrant splicing and B cell infiltration in breast cancer hormone therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine-related cancer"
DOI: 10.1530/erc-21-0199
Abstract: Increasing evidence has suggested alternative splicing (AS) is an essential mechanism for tumor initiation and progression. However, the functions of aberrant splicing have not been well understood in hormone therapy-treated breast cancer (HTBC) patients. By… read more here.
Keywords: cancer; cell; htbc patients; aberrant splicing ... See more keywords